{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:53:52Z","timestamp":1773212032800,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1331\/1544-3191.44.5.604.brennan","type":"journal-article","created":{"date-parts":[[2007,3,30]],"date-time":"2007-03-30T16:11:54Z","timestamp":1175271114000},"page":"604-611","source":"Crossref","is-referenced-by-count":6,"title":["Eplerenone: Selective Aldosterone Antagonism in Management of Cardiovascular and Renal Disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Barbara J.","family":"Brennan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0010","series-title":"2002 heart and stroke statistical update","author":"American Heart Association","year":"2001"},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0015","first-page":"438","article-title":"Notice to readers: national high blood pressure education month, May 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0167-5273(99)00182-5","article-title":"Left ventricular remodeling and dysfunction can the process be prevented?","volume":"72","author":"Willenheimer","year":"2000","journal-title":"Int J Cardiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0025","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circ Res."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0030","first-page":"E657","article-title":"Determinants of cardiac fibrosis in experimental hypertension","volume":"269","author":"Young","year":"1995","journal-title":"Am J Physiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0035","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00045415-200203000-00008","article-title":"Aldosterone as a mediator in cardiovascular injury","volume":"10","author":"Stier","year":"2002","journal-title":"Cardiol Rev."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.ph.50.030188.002205","article-title":"Regulation of aldosterone secretion","volume":"50","author":"Quinn","year":"1988","journal-title":"Rev Physiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0050","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.100.10.1056","article-title":"Comparison of candesartan, enalapril, and their combination in congestive heart failure","volume":"100","author":"McKelvie","year":"1999","journal-title":"Circulation"},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.25.2.170","article-title":"Production of aldosterone in isolated rat blood vessels","volume":"25","author":"Takeda","year":"1995","journal-title":"Hypertension"},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0060","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat","volume":"273","author":"Sylvestre","year":"1998","journal-title":"J Biol Chem."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0065","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","article-title":"Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension","volume":"71","author":"Brilla","year":"1993","journal-title":"Am J Cardiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0070","doi-asserted-by":"crossref","first-page":"H647","DOI":"10.1152\/ajpheart.2001.281.2.H647","article-title":"Effect of a selective aldosterone antagonist in myocardial infarction","volume":"50","author":"Delyani","year":"2001","journal-title":"Am J Heart Circ Physiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.33.1.232","article-title":"Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats","volume":"33","author":"Rocha","year":"1999","journal-title":"Hypertension."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0085","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.HYP.32.6.965","article-title":"Effect of activation and inhibition of the renin\u2013angiotensin system on plasma PAI-1","volume":"32","author":"Brown","year":"1998","journal-title":"Hypertension."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0922-4106(95)90018-7","article-title":"Aldosterone inhibits nitric oxide synthesis in rat vascular smooth muscle cells induced by interleukin-1 beta","volume":"290","author":"Ikeda","year":"1995","journal-title":"Eur J Pharmacol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0095","first-page":"E649","article-title":"ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension","volume":"258","author":"Gomez-Sanchez","year":"1990","journal-title":"Am J Physiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0100","doi-asserted-by":"crossref","first-page":"C175","DOI":"10.1152\/ajpcell.1998.274.1.C175","article-title":"Na+influx and Na+K+ pump activation during short-term exposure of cardiac myocytes to aldosterone","volume":"274","author":"Milhailidou","year":"1998","journal-title":"Am J Physiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0110","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0115","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1527-3466.2001.tb00064.x","article-title":"Eplerenone: a selective aldosterone receptor antagonist","volume":"19","author":"Delyani","year":"2001","journal-title":"Cardiovasc Drug Rev."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0125","first-page":"598","article-title":"Role of mineralocorticoids in renal injury in stroke-prone hypertensive rats","volume":"32","author":"Rocha","year":"1998","journal-title":"Hypertension."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0130","first-page":"S13","article-title":"Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period","volume":"4","author":"Borrello","year":"2003","journal-title":"Rev Cardiovasc Med."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/01.CIR.0000019582.39797.EF","article-title":"Beta-blockers in the post-myocardial infarction patient","volume":"106","author":"Gheorghiade","year":"2002","journal-title":"Circulation."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0140","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1001\/jama.284.21.2748","article-title":"Health and economic benefits of increased beta-blocker use following myocardial infarction","volume":"284","author":"Phillips","year":"2000","journal-title":"JAMA."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0145","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.0000025146.19104.FE","article-title":"Efficacy of eplerenone added to renin\u2013angiotensin blockade in hypertensive patients","volume":"40","author":"Krum","year":"2002","journal-title":"Hypertension."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/S0895-7061(02)02332-4","article-title":"Efficacy and safety of eplerenone, enalapril, and eplerenone\/enalapril combination therapy in patients with left ventricular hypertrophy","author":"Pitt","year":"2002"},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(02)81115-9","article-title":"Eplerenone reduces proteinuria in type 2 diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction","author":"Epstein","year":"2002"},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0165","doi-asserted-by":"crossref","first-page":"24A","DOI":"10.1016\/S0895-7061(02)02334-8","article-title":"Comparison of eplerenone and losartan in patients with low-renin hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens."},{"key":"10.1331\/1544-3191.44.5.604.Brennan_bb0170","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction: a meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet."}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911531791X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431911531791X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T19:11:23Z","timestamp":1556305883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431911531791X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S154431911531791X"],"URL":"https:\/\/doi.org\/10.1331\/1544-3191.44.5.604.brennan","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}